Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells

International Journal of Oncology

Volumn 38, Issue 6, 2011, Pages 1759-1766

  Kim, Chul Jang ^a   Sakamoto, Kanami ^b,c   Tambe, Yukihiro ^b   Inoue, Hirokazu ^b  

^a Kohka Public Hospital   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Bladder cancer; Cell invasiveness; Epithelial to mesenchymal transition; Periostin; Prostate cancer

Indexed keywords

PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CADHERINS; CELL ADHESION MOLECULES; CELL DEDIFFERENTIATION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MALE; MICE; NEOPLASM INVASIVENESS; NIH 3T3 CELLS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS;

EID: 79955838431     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.997     Document Type: Article

References (29)

1. Thiery JP and Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142, 2006. (Pubitemid 43278296)
2. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2001.
3. Birchmeier W and Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198: 11-26, 1994. (Pubitemid 24159061)
4. Lindsley A, Snider P, Zhou H, et al: Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. Dev Biol 307: 340-355, 2007. (Pubitemid 47007685)
5. Bao S, Ouyang G, Bai X, et al: Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5: 329-339, 2004. (Pubitemid 38482069)
6. Shao R, Bao S, Bai X, et al: Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through upregulation of vascular endothelial growth factor 2 expression. Mol Cell Biol 24: 3992-4003, 2004. (Pubitemid 38496176)
7. Sasaki H, Lo KM, Chen LB, et al: Expression of periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers. Jpn J Cancer Res 92: 869-873, 2001. (Pubitemid 32894097)
8. Kudo Y, Ogawa I, Kitajima S, et al: Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66: 6928-6935, 2006. (Pubitemid 44197667)
9. Siriwardena BS, Kudo Y, Ogawa I, et al: Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer 95: 1396-1403, 2006. (Pubitemid 44760092)
10. Baril P, Gangeswaran R, Mahon PC, et al: Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the β4 integrin and the PI3k pathway. Oncogene 26: 2082-2094, 2007. (Pubitemid 46514745)
11. Soltermann A, Tischler V, Arbogast S, et al: Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 14: 7430-7437, 2008.
12. Kim CJ, Yoshioka N, Tambe Y, Kushima R, Okada Y and Inoue H: Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. Int J Cancer 117: 51-58, 2005. (Pubitemid 41262759)
13. Kim CJ, Isono T, Tambe Y, et al: Role of alternative splicing of periostin in human bladder carcinogenesis. Int J Oncol 32: 161-169, 2008. (Pubitemid 351176074)
14. Yoshioka N, Fuji S, Shimakage M, et al: Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene. Exp Cell Res 279: 91-99, 2002.
15. Naviaux RK, Constanzi E, Haas M and Verma IM: The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 70: 5701-5705, 1996. (Pubitemid 26240755)
16. Hong L, Sun H, Lv X, Yang D, Zhang J and Shi Y: Expression of periostin in the serum of NSCLC and its function on proliferation and migration of human lung adenocarcinoma cell line (A549) in vitro. Mol Biol Rep 37: 2285-2293, 2010.
17. Giroldi LA, Bringuier PP, de Weijert M, Jansen C, van Bokhoven A and Schalken JA: Role of E boxes in the repression of E-cadherin expression. Biochem Biophys Res Commun 241: 453-458, 1997. (Pubitemid 28020121)
18. Batlle E, Sancho E, Franci C, et al: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
19. Cheng GZ, Park S, Shu S, et al: Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets 8: 2-6, 2008. (Pubitemid 351237904)
20. Christiansen JJ and Rajasekaran AK: Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66: 8319-8326, 2006. (Pubitemid 44449137)
21. Rieger-Christ KM, Ng L, Hanley RS, et al: Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br J Cancer 92: 2153-2159, 2005. (Pubitemid 40966250)
22. Gravdal K, Halvorsen OJ, Haukaas SA and Akslen LA: A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13: 7003-7011, 2007. (Pubitemid 350276881)
23. Tsunoda T, Furusato B, Takashima Y, et al: The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma. Prostate 69: 1398-1403, 2009.
24. Julien S, Puig I, Caretti E, et al: Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchymal transition. Oncogene 26: 7445-7456, 2007. (Pubitemid 350158710)
25. Lim J, Kim JH, Paeng JY, et al: Prognostic value of activated Akt expression in oral squamous cell carcinoma. J Clin Pathol 58: 1199-1205, 2005. (Pubitemid 41566467)
26. Grille SJ, Bellacosa A, Upson J, et al: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003. (Pubitemid 36538623)
27. Erkan M, Kleeff J, Gorbachevski A, et al: Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology 132: 1447-1464, 2007. (Pubitemid 46627568)
28. Harris LD, De La Cerda J, Tuziak T, et al: Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray. Mol Carcinog 47: 678-685, 2008.
29. Malik SN, Brattain M, Ghosh PM, et al: Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin Cancer Res 8: 1168-1171, 2002. (Pubitemid 35177371)